Skip to content
In deliveryUnited Kingdom

ENHERTU (TRASTUZUMAB DERUXTECAN) 100MG POWDER FOR CONCENTRATE FOR SOLN FOR INFUSION VIAL

Published
Published 13 August 2025

Overview

The intended contract is for the supply of Enhertu (Trastuzumab Deruxtecan) 100mg powder for solution for infusion to Northern Health and Social Care Trust for the period of three years

Key details

Country
United Kingdom
Status
In delivery
Procedure
Direct
Published
13 August 2025

Award outcome

Awarded value
£700,000
Award date
12 August 2025
Contract period
31 August 2025 → 31 August 2028
Winners
  • ALLOGA UK LIMITED
  • NOVARTIS PHARMACEUTICALS UK LIMITED

Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.

Notice history

Every published notice in this contracting process, newest first.

  1. Contract

    3 September 2025

    View notice ↗
  2. Contract

    14 August 2025

    View notice ↗
  3. Contract

    13 August 2025

    View notice ↗

Contracting authority

  • Northern Health And Social Care Trust

    Buyer

    Antrim, United Kingdom

    GB-PPON: PBRP-6676-CQZY

Get the full picture

AI analysis, bid scoring, and expert strategy for this tender

Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.

See which competitors are winning the contracts you're chasing.

15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.

Awarded: ENHERTU (TRASTUZUMAB DERUXTECAN) 100MG POWDER FOR CONCENTRATE FOR SOLN FOR INFUSION VIAL — won by ALLOGA UK LIMITED +1 — Skim